Stockcalc – Free Trial
Have a free look inside the StockCalc website at www.stockcalc.com
Fully Valued Stocks on AMEX
Today we are looking at companies that are considered fully valued based on the Analyst data in the StockCalc database.
In this table we can see the close price and target price for these companies along with the number of analysts covering the stock. We also have included the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year.
There can be a number of reasons why a company would be on this list. What is particularly interesting are companies with a large analyst following that make this list. We need to dig deeper into these companies to understand why the difference in price versus target.
Today’s Data on AMEX
Today’s data is for companies listed on the American Stock Exchange.
|Symbol||Name||Target Year||Close Price||Target Price Mean||Currency||Target Price # of Estimates|
|CQP||Cheniere Energy Partners LP||2019||42.420000||40.0000||USD||4|
|SENS||Senseonics Holdings Inc||2019||2.580000||2.3750||USD||2|
|NBY||NovaBay Pharmaceuticals Inc||2019||1.252500||1.2500||USD||1|
Let’s look at a few companies…
Lets look at a couple of the companies on this list to get a better understanding of them.
CQP:ASE Cheniere Energy Partners
Cheniere Energy Partners has 1372 employees and is headquartered in United States.
Cheniere Energy Partners LP engages in the liquified natural gas export business. The firm operates through its Sabine Pass liquefaction/terminal/pipeline facilities in Louisiana.
SENS:ASE Senseonics Holdings
Senseonics Holdings has 192 employees and is headquartered in United States.
Senseonics Holdings Inc is a medical technology company engaged in designing, development and commercialization of glucose monitoring systems for diabetes patients.
The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.